| Predicted Trait | |
| Reported Trait | Prostate cancer |
| Mapped Trait(s) | prostate carcinoma (EFO_0001663) |
| Score Construction | |
| PGS Name | CC_Prostate_IV |
| Development Method | |
| Name | 161 variants from Graff et al (PGS000084) with inverse variant weights |
| Parameters | NR |
| Variants | |
| Original Genome Build | GRCh37 |
| Number of Variants | 161 |
| Effect Weight Type | Inverse-variance weighting |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000186 |
| Citation (link to publication) | Kachuri L et al. Nat Commun (2020) |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST003587 Europe PMC: 27197191 |
123,671 individuals | European | GAME-ON, GECCO |
GWAS Catalog: GCST001942 Europe PMC: 23535732 |
22,548 individuals | European | NR |
GWAS Catalog: GCST002606 Europe PMC: 25217961 |
2,080 individuals | Hispanic or Latin American | NR |
GWAS Catalog: GCST002606 Europe PMC: 25217961 |
6,954 individuals | East Asian | NR |
GWAS Catalog: GCST002606 Europe PMC: 25217961 |
10,463 individuals | Sub-Saharan African, African American or Afro-Caribbean | NR |
GWAS Catalog: GCST002606 Europe PMC: 25217961 |
67,543 individuals | European | NR |
GWAS Catalog: GCST002890 Europe PMC: 25939597 |
7,541 individuals | European | PLCO |
GWAS Catalog: GCST002944 Europe PMC: 26034056 |
3,226 individuals | East Asian | CMHS, GERA, ProHealth, RPGEH |
GWAS Catalog: GCST000152 Europe PMC: 18264097 |
3,748 individuals | European | ProtecT, UKGPCS |
Europe PMC: 26881390 |
[ ,
100.0 % Male samples |
East Asian (Han Chinese) |
CHIPGECS |
GWAS Catalog: GCST001338 Europe PMC: 22130093 |
545 individuals | Not reported | NR |
GWAS Catalog: GCST006085 Europe PMC: 29892016 |
140,254 individuals | European | NR |
GWAS Catalog: GCST001147 Europe PMC: 21743057 |
7,240 individuals | European | NR |
GWAS Catalog: GCST002421 Europe PMC: 24753544 |
2,950 individuals | European | ProtecT |
GWAS Catalog: GCST002944 Europe PMC: 26034056 |
2,251 individuals | African American or Afro-Caribbean | CMHS, GERA, ProHealth, RPGEH |
GWAS Catalog: GCST002944 Europe PMC: 26034056 |
3,629 individuals | Hispanic or Latin American | CMHS, GERA, ProHealth, RPGEH |
GWAS Catalog: GCST002944 Europe PMC: 26034056 |
37,272 individuals | European | CMHS, GERA, ProHealth, RPGEH |
GWAS Catalog: GCST002413 Europe PMC: 24740154 |
5,051 individuals | European | Illumina_iControlDB, dbGAP |
| — | [ ,
100.0 % Male samples |
European | 37 cohorts
|
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM002066 | PSS001023| European Ancestry| 184,225 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Reported Trait: Incident prostate cancer | HR: 1.77 [1.72, 1.82] | AUROC: 0.769 C-index: 0.768 (0.004) |
R²: 0.51 | Age at assessment, family history of prostate cancer, genotyping array, PCs(1-15), family history of prostate cancer | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
| PPM002069 | PSS001023| European Ancestry| 184,225 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Reported Trait: Incident prostate cancer | — | AUROC: 0.766 C-index: 0.763 (0.004) |
R²: 0.496 | Age, genotyping array, PCs(1-15) | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS001023 | Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases. | — | [ ,
100.0 % Male samples |
— | European | — | UKB | — |